Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents' use and substance use disorder symptoms in adulthood
- PMID: 27569697
- PMCID: PMC5462596
- DOI: 10.1016/j.addbeh.2016.08.021
Medical and nonmedical use of prescription sedatives and anxiolytics: Adolescents' use and substance use disorder symptoms in adulthood
Abstract
Objectives: This study assessed the longitudinal associations between medical and nonmedical use of prescription sedatives/anxiolytics (NMPSA) during adolescence (age 18) and substance use disorder (SUD) symptoms during adulthood (age 35).
Methods: Multiple cohorts of nationally representative samples of U.S. high school seniors (n=8373) were surveyed via self-administered questionnaires and followed longitudinally from adolescence (age 18, 1976-1996) to adulthood (age 35, 1993-2013).
Results: An estimated 20.1% of adolescents reported lifetime medical or nonmedical use of prescription sedatives/anxiolytics. Among adolescents who reported medical use of prescription sedatives/anxiolytics, 44.9% also reported NMPSA by age 18. Based on multivariate analyses that included age 18 sociodemographic and other substance use controls, medical use of prescription sedatives/anxiolytics without any history of NMPSA during adolescence was not associated with SUD symptoms in adulthood relative to adolescents with no prescription sedative/anxiolytic use. In contrast, adolescents with a history of both medical and nonmedical use of prescription sedatives/anxiolytics and adolescents who reported only NMPSA had between two to three times greater odds of SUD symptoms in adulthood relative to adolescents with no prescription sedative/anxiolytic use and those who reported only medical use of prescription sedatives/anxiolytics.
Conclusions: One in every five U.S. high school seniors reported ever using prescription sedatives/anxiolytics either medically or nonmedically. This study provides compelling evidence that the medical use of prescription sedatives/anxiolytics (without any NMPSA) during adolescence is not associated with increased risk of SUD symptoms in adulthood while any NMPSA during adolescence serves as a signal for SUDs in adulthood.
Keywords: Anxiolytic; Longitudinal; Medical use; Nonmedical use; Sedative; Substance use disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
All authors declare that they have no conflicts of interest.
Similar articles
-
Medical and nonmedical use of prescription benzodiazepine anxiolytics among U.S. high school seniors.Addict Behav. 2014 May;39(5):959-64. doi: 10.1016/j.addbeh.2014.01.009. Epub 2014 Jan 28. Addict Behav. 2014. PMID: 24556157 Free PMC article.
-
Adolescents' Prescription Stimulant Use and Adult Functional Outcomes: A National Prospective Study.J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):226-233.e4. doi: 10.1016/j.jaac.2016.12.008. Epub 2016 Dec 25. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 28219488 Free PMC article.
-
Longitudinal Analysis of Substance Use Disorder Symptom Severity at Age 18 Years and Substance Use Disorder in Adulthood.JAMA Netw Open. 2022 Apr 1;5(4):e225324. doi: 10.1001/jamanetworkopen.2022.5324. JAMA Netw Open. 2022. PMID: 35363270 Free PMC article.
-
A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife.Drug Alcohol Depend. 2019 Jan 1;194:377-385. doi: 10.1016/j.drugalcdep.2018.10.027. Epub 2018 Nov 15. Drug Alcohol Depend. 2019. PMID: 30481692 Free PMC article.
-
Nonmedical use of prescription medications among adolescents in the United States: a systematic review.J Adolesc Health. 2012 Jul;51(1):6-17. doi: 10.1016/j.jadohealth.2012.01.011. Epub 2012 Apr 4. J Adolesc Health. 2012. PMID: 22727071 Review.
Cited by
-
Suicide Attempt and Risk of Substance Use Disorders Among Female Youths.JAMA Psychiatry. 2022 Jul 1;79(7):710-717. doi: 10.1001/jamapsychiatry.2022.1025. JAMA Psychiatry. 2022. PMID: 35544235
-
Age 18-30 trajectories of binge drinking frequency and prevalence across the past 30 years for men and women: Delineating when and why historical trends reversed across age.Dev Psychopathol. 2022 Jan 24:1-15. doi: 10.1017/S0954579421001218. Online ahead of print. Dev Psychopathol. 2022. PMID: 35068407
-
Cohort and age trends in age 35-45 prevalence of alcohol use disorder symptomology, by severity, sex, race, and education.Drug Alcohol Depend. 2021 Sep 1;226:108820. doi: 10.1016/j.drugalcdep.2021.108820. Epub 2021 Jun 25. Drug Alcohol Depend. 2021. PMID: 34245999 Free PMC article.
-
Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways.Front Psychiatry. 2021 Apr 27;12:640766. doi: 10.3389/fpsyt.2021.640766. eCollection 2021. Front Psychiatry. 2021. PMID: 33986700 Free PMC article.
-
Effects of depression, anxiety and screen use on adolescent substance use.Prev Med Rep. 2021 Apr 3;22:101362. doi: 10.1016/j.pmedr.2021.101362. eCollection 2021 Jun. Prev Med Rep. 2021. PMID: 33898206 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
